VRCA - Verrica Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
356.73M
Enterprise Value 3
279.94M
Trailing P/E
N/A
Forward P/E 1
-5.41
PEG Ratio (5 yr expected) 1
0.13
Price/Sales (ttm)
N/A
Price/Book (mrq)
4.97
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-9.26

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 333.30%
S&P500 52-Week Change 318.19%
52 Week High 318.67
52 Week Low 36.44
50-Day Moving Average 314.66
200-Day Moving Average 311.88

Share Statistics

Avg Vol (3 month) 380.25k
Avg Vol (10 day) 397.98k
Shares Outstanding 525.78M
Float 7.77M
% Held by Insiders 152.83%
% Held by Institutions 132.98%
Shares Short (Nov 15, 2019) 4635.48k
Short Ratio (Nov 15, 2019) 410.32
Short % of Float (Nov 15, 2019) 46.78%
Short % of Shares Outstanding (Nov 15, 2019) 42.47%
Shares Short (prior month Oct 15, 2019) 4577.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.64%
Return on Equity (ttm)-33.51%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -30.23M
Net Income Avi to Common (ttm)-28.15M
Diluted EPS (ttm)-1.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.08M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)218k
Total Debt/Equity (mrq)0.30
Current Ratio (mrq)17.10
Book Value Per Share (mrq)2.78

Cash Flow Statement

Operating Cash Flow (ttm)-26.1M
Levered Free Cash Flow (ttm)-16.4M